查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1616813

數位糖尿病管理的全球市場:各產品類型，各終端用戶，各零件，各地區，範圍及預測

Global Digital Diabetes Management Market by Product, By Type, By End User, By Component, By Geographic Scope and Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

數位糖尿病管理市場規模及預測

2024 年數位糖尿病管理市場估值為 171.1 億美元，預計 2024 年至 2031 年複合年增長率為 13.10%，到 2031 年將達到 464.6 億美元。數位糖尿病管理是利用數位技術和連接設備來監測、管理和治療糖尿病，為患者和醫療保健提供者提供即時數據和見解。這些解決方案包括從智慧血糖儀到胰島素輸送系統等各種產品，旨在改善血糖控制、增強患者參與度並降低糖尿病相關併發症的風險。

數位糖尿病管理的未來在於整合人工智慧、機器學習和大數據分析，以提供更個人化和預測性的護理，從而可能徹底改變糖尿病的治療和預防策略。

全球數位糖尿病管理市場動態

塑造全球數位糖尿病管理市場的關鍵市場動態是：

主要市場驅動因子

糖尿病盛行率增加：

全球糖尿病患者數量激增，尤其是在新興市場，增加了對高效數位管理工具的需求，以有效監測和管理病情，從而推動市場成長。

技術進步：

感測器、行動技術和數據分析的技術創新顯著改善了數位糖尿病管理工具，使患者和醫療保健提供者更易於使用、更準確、更有效率。

連接設備的普及：

智慧型手機和穿戴式科技的普及將推動數位糖尿病管理解決方案的採用，加強患者和醫療保健專業人員之間的溝通，並實現更好的護理協調。

關注預防保健：

向預防性醫療保健和個人化醫療的轉變正在增加數位工具的使用，以進行糖尿病的早期檢測和預防性管理，這有望減少長期併發症並改善患者的治療結果。

主要問題

資料隱私與安全問題：

敏感健康資料的收集和傳輸會帶來嚴重的隱私和網路安全問題，並可能阻礙全球糖尿病數位管理市場的成長。

監理障礙：

各地區對醫療設備和軟體的嚴格監管要求可能會延遲產品批准和市場進入，給尋求實施創新糖尿病管理解決方案的公司帶來挑戰。

主要趨勢：

人工智慧整合：

將人工智慧和機器學習融入糖尿病管理工具中，可提供預測性見解和個人化建議，從而提高這些解決方案的有效性和使用者體驗。

遠距醫療的興起：

在 COVID-19 大流行的推動下，遠距醫療的接受度不斷提高，正在推動數位糖尿病管理解決方案中遠端監控和虛擬諮詢功能的採用，以增強患者護理。

生態系方法：

越來越多的公司正在採用全面的生態系統方法進行糖尿病管理，各整合種設備、應用程式和服務，為患者提供全面、協調的護理體驗。

目錄

第1章 全球數位糖尿病管理市場:簡介

  • 市場定義
  • 市場區隔
  • 調查時間軸
  • 前提條件
  • 限制

第2章 檢驗市場調查的調查手法

  • 資料探勘
  • 資料的三角測量
  • Bottom-Up(由下而上)方法
  • Top-Down(由上而下)方法
  • 調查的流程
  • 產業專家的重要洞察
  • 資料來源

第3章 摘要整理

  • 市場概要
  • 生態學製圖
  • 絕對的商機
  • 市場魅力
  • 數位糖尿病管理的全球市場各地區分析(年複合成長率)
  • 數位糖尿病管理的全球市場:各產品(金額)
  • 數位糖尿病管理的全球市場:各類型(金額)
  • 數位糖尿病管理的全球市場:各用途(金額)
  • 今後的市場機會
  • 全球市場分割
  • 產品life line

第4章 數位糖尿病管理的全球市場展望

  • 數位糖尿病管理的世界演進
  • 促進因素
  • 阻礙因素
  • 機會
  • 波特的五力分析
  • 價值鏈分析
  • 價格分析
  • 宏觀經濟分析

第5章 數位糖尿病管理的全球市場:各產品

  • 概要
  • 智慧血糖計
  • 持續血糖監測系統
  • 智慧胰島素筆針
  • 智慧胰島素幫浦
  • APPS類

第6章 數位糖尿病管理的全球市場:各類型

  • 概要
  • 穿戴式設備
  • 手持設備

第7章 數位糖尿病管理的全球市場:各終端用戶

  • 概要
  • 醫院
  • 家庭套組
  • 診斷中心

第8章 數位糖尿病管理的全球市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 南美
    • 巴西
    • 阿根廷
    • 其他南美國家
  • 中東·非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
    • 其他中東和非洲

第9章 全球數位糖尿病管理市場:競爭情形

  • 概要
  • 各公司的市場排行榜
  • 主要的發展
  • 各地區足跡
  • 企業的產業足跡
  • ACE MATRIX

第10章 企業簡介

  • ABBOTT LABORATORIES
  • MEDTRONIC PLC
  • F. HOFFMANN-LA ROCHE LTD.
  • BAYER AG
  • LIFESCAN, INC.
  • DEXCOM, INC.
  • SANOFI
  • INSULET CORPORATION
  • ASCENSIA DIABETES CARE HOLDINGS AG
  • B BRAUN MELSUNGEN AG
  • ABOUT VERIFIED MARKET RESEARCH
  • DYNAMIC DATA VISUALIZATION
簡介目錄
Product Code: 7541

Digital Diabetes Management Market Size And Forecast

Digital Diabetes Management Market was valued at USD 17.11 Billion in 2024 and is projected to reach USD 46.46 Billion by 2031 growing at a CAGR of 13.10% from 2024 to 2031. Digital Diabetes Management refers to the use of digital technologies and connected devices to monitor, manage and treat diabetes, providing real-time data and insights to both patients and healthcare providers. These solutions encompass a range of products from smart glucose meters to insulin delivery systems, aiming to improve glycemic control, enhance patient engagement and reduce the risk of diabetes-related complications.

The future scope of digital diabetes management lies in the integration of artificial intelligence, machine learning and big data analytics to provide more personalized and predictive care, potentially revolutionizing diabetes treatment and prevention strategies.

Global Digital Diabetes Management Market Dynamics

The key market dynamics that are shaping the global digital diabetes management market include:

Key Market Drivers:

Rising Prevalence of Diabetes:

The global surge in diabetes cases, especially in developing regions, is increasing the need for efficient digital management tools to monitor and control the condition effectively, boosting market growth.

Technological Advancements:

Innovations in sensors, mobile technology and data analytics are significantly improving digital diabetes management tools, making them more user-friendly, precise and efficient for both patients and healthcare providers globally.

Growing Adoption of Connected Devices:

The widespread use of smartphones and wearable technology is driving greater adoption of digital diabetes management solutions, enhancing communication between patients and healthcare providers for better care coordination.

Focus on Preventive Healthcare:

The shift towards preventive healthcare and personalized medicine is increasing the use of digital tools for early diabetes detection and proactive management, reducing long-term complications and improving patient outcomes.

Key Challenges:

Data Privacy and Security Concerns:

The collection and transmission of sensitive health data pose significant privacy and cybersecurity concerns, which can hinder the growth of the global diabetes digital management market.

Regulatory Hurdles:

Strict regulatory requirements for medical devices and software across various regions can delay product approvals and market entry, creating challenges for companies aiming to introduce innovative diabetes management solutions.

Key Trends:

Integration of Artificial Intelligence:

The incorporation of artificial intelligence and machine learning into diabetes management tools is providing predictive insights and personalized recommendations, enhancing the effectiveness and user experience of these solutions.

Rise of Telemedicine:

The growing acceptance of telemedicine, accelerated by the COVID-19 pandemic, is significantly driving the adoption of remote monitoring and virtual consultation features within digital diabetes management solutions for enhanced patient care.

Ecosystem Approach:

Companies are increasingly adopting a comprehensive ecosystem approach in diabetes management, integrating various devices, applications and services to provide a holistic and coordinated care experience for patients.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Digital Diabetes Management Market Regional Analysis

Here is a more detailed regional analysis of the global digital diabetes management market:

North America:

According to Verified Market Research, North America is expected to dominate the Global digital diabetes management market.

The region benefits from advanced healthcare infrastructure, high diabetes prevalence and early adoption of digital health technologies, driving its market dominance in the sector.

Strong presence of major market players and favorable reimbursement policies in countries like the U.S. and Canada contribute to the region's leading position.

The growing emphasis on value-based care and patient-centric approaches in North America supports the adoption of digital diabetes management solutions.

Increasing investments in digital health startups and collaborations between technology companies and healthcare providers fuel innovation in the region.

Asia-Pacific:

According to Verified Market Research, Asia-Pacific is the fastest growing region in Global digital diabetes management market.

The Asia-Pacific region is experiencing a rapid increase in diabetes prevalence, creating a significant demand for effective management solutions.

Rising disposable incomes, improving healthcare infrastructure and increasing awareness about diabetes management in countries like China and India drive market growth.

Government initiatives to promote digital health and improve diabetes care in several Asian countries contribute to the rapid adoption of digital management tools.

The large population base and increasing penetration of smartphones and internet connectivity in the region support the swift market expansion.

Global Digital Diabetes Management Market Segmentation Analysis

The Global Digital Diabetes Management Market is Segmented on the Basis of Product, Type, End-User, And Geography.

Digital Diabetes Management Market, By Product

  • Smart Glucose Meters
  • Continuous Glucose Monitoring Systems
  • Smart Insulin Pens
  • Smart Insulin Pumps
  • Others

Based on Product, the Digital Diabetes Management market is segmented into Smart Glucose Meters, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps and Others. Continuous Glucose Monitoring Systems (CGMs) are the most dominating product segment, driven by their ability to provide real-time, continuous glucose data without the need for frequent finger pricks. The increasing preference for CGMs among both Type 1 and Type 2 diabetes patients, coupled with their integration with insulin delivery systems, contributes significantly to their market dominance.

Digital Diabetes Management Market, By Type

  • Wearable Devices
  • Handheld Devices

Based on Type, the Digital Diabetes Management market is categorized into Wearable Devices and Handheld Devices. Wearable Devices are the most dominating type, driven by their convenience, continuous monitoring capabilities and seamless integration with smartphones and other connected devices. The growing consumer preference for non-invasive and discreet monitoring solutions, along with advancements in sensor technologies, supports the dominance of wearable devices in the digital diabetes management market.

Digital Diabetes Management Market, By End-User

  • Hospitals & Specialty Clinics
  • Home Care Settings
  • Academic & Research Institutes

Based on End-User, the Digital Diabetes Management market is segmented into Hospitals & Specialty Clinics, Home Care Settings and Academic & Research Institutes. Home Care Settings is the most dominating end-user segment, driven by the increasing trend towards self-management of diabetes and the growing preference for remote monitoring solutions. The convenience and cost-effectiveness of managing diabetes at home, coupled with the rising adoption of telemedicine, contribute significantly to the dominance of this segment.

Digital Diabetes Management Market, By Component

  • Devices
  • Apps & Software
  • Services

Based on Component, the Digital Diabetes Management market is segmented into Devices, Apps & Software and Services. Devices are the most dominating component, driven by the essential role of hardware in glucose monitoring and insulin delivery. The continuous innovations in device technologies, such as improved accuracy, miniaturization and connectivity features, support their significant market share and dominance in the digital diabetes management ecosystem.

Digital Diabetes Management Market, By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Based on Geography, the Digital Diabetes Management market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa. North America is both the largest and one of the fastest-growing regions, driven by high diabetes prevalence, advanced healthcare infrastructure and early adoption of digital health technologies. The region's strong focus on innovation, favorable reimbursement policies and presence of key market players contribute significantly to its market dominance and continued rapid growth.

Key Players

  • The Global "Digital Diabetes Management Market" study report will provide valuable insight with an emphasis on the global market. The major players in the Digital Diabetes Management Market include
  • Medtronic, Dexcom, Inc., Insulet Corporation, Abbott Laboratories, Tandem Diabetes Care, Lifescan, Inc., Ascensia Diabetes Care, Tidepool, Glooko, Inc. and H2 Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above- mentioned players globally.

  • Digital Diabetes Management Market Recent Developments
  • In January 2024, Medtronic launched an advanced closed-loop insulin delivery system with enhanced AI capabilities, aiming to improve glucose control and reduce the burden of diabetes management for patients.
  • In March 2024, Dexcom, Inc. announced a partnership with a major telehealth provider to integrate its CGM data into virtual diabetes care platforms, expanding access to remote monitoring and management services.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL DIGITAL DIABETES MANAGEMENT MARKET

  • 1.1 MARKET DEFINITION
  • 1.2 MARKET SEGMENTATION
  • 1.3 RESEARCH TIMELINES
  • 1.4 ASSUMPTIONS
  • 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 2.1 DATA MINING
  • 2.2 DATA TRIANGULATION
  • 2.3 BOTTOM-UP APPROACH
  • 2.4 TOP-DOWN APPROACH
  • 2.5 RESEARCH FLOW
  • 2.6 KEY INSIGHTS FROM INDUSTRY EXPERTS
  • 2.7 DATA SOURCES

3 EXECUTIVE SUMMARY

  • 3.1 MARKET OVERVIEW
  • 3.2 ECOLOGY MAPPING
  • 3.3 ABSOLUTE MARKET OPPORTUNITY
  • 3.4 MARKET ATTRACTIVENESS
  • 3.5 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
  • 3.6 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT (USD MILLION)
  • 3.7 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE (USD MILLION)
  • 3.8 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY APPLICATION (USD MILLION)
  • 3.9 FUTURE MARKET OPPORTUNITIES
  • 3.10 GLOBAL MARKET SPLIT
  • 3.11 PRODUCT LIFE LINE

4 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET OUTLOOK

  • 4.1 GLOBAL DIGITAL DIABETES MANAGEMENT EVOLUTION
  • 4.2 DRIVERS
    • 4.2.1 DRIVER 1
    • 4.2.2 DRIVER 2
  • 4.3 RESTRAINTS
    • 4.3.1 RESTRAINT 1
    • 4.3.2 RESTRAINT 2
  • 4.4 OPPORTUNITIES
    • 4.4.1 OPPORTUNITY 1
    • 4.4.2 OPPORTUNITY 2
  • 4.5 PORTERS FIVE FORCE MODEL
  • 4.6 VALUE CHAIN ANALYSIS
  • 4.7 PRICING ANALYSIS
  • 4.8 MACROECONOMIC ANALYSIS

5 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT

  • 5.1 OVERVIEW
  • 5.2 SMART GLUCOSE METER
  • 5.3 CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEM
  • 5.4 SMART INSULIN PENS
  • 5.5 SMART INSULIN PUMPS
  • 5.6 APPS

6 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE

  • 6.1 OVERVIEW
  • 6.2 WEARABLE DEVICES
  • 6.3 HANDHELD DEVICES

7 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY END-USER

  • 7.1 OVERVIEW
  • 7.2 HOSPITALS
  • 7.3 HOME SETTINGS
  • 7.4 DIAGNOSTIC CENTERS EXTERIOR

8 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY GEOGRAPHY

  • 8.1 OVERVIEW
  • 8.2 NORTH AMERICA
    • 8.2.1 U.S.
    • 8.2.2 CANADA
    • 8.2.3 MEXICO
  • 8.3 EUROPE
    • 8.3.1 GERMANY
    • 8.3.2 U.K.
    • 8.3.3 FRANCE
    • 8.3.4 ITALY
    • 8.3.5 SPAIN
    • 8.3.6 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • 8.4.1 CHINA
    • 8.4.2 JAPAN
    • 8.4.3 INDIA
    • 8.4.4 REST OF ASIA PACIFIC
  • 8.5 LATIN AMERICA
    • 8.5.1 BRAZIL
    • 8.5.2 ARGENTINA
    • 8.5.3 REST OF LATIN AMERICA
  • 8.6 MIDDLE-EAST AND AFRICA
    • 8.6.1 UAE
    • 8.6.2 SAUDI ARABIA
    • 8.6.3 SOUTH AFRICA
    • 8.6.4 REST OF MIDDLE-EAST AND AFRICA

9 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 COMPANY MARKET RANKING
  • 9.3 KEY DEVELOPMENTS
  • 9.4 COMPANY REGIONAL FOOTPRINT
  • 9.5 COMPANY INDUSTRY FOOTPRINT
  • 9.6 ACE MATRIX

10 COMPANY PROFILES

  • 10.1 ABBOTT LABORATORIES
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 COMPANY INSIGHTS
    • 10.1.3 PRODUCT BENCHMARKING
    • 10.1.4 KEY DEVELOPMENT
    • 10.1.5 WINNING IMPERATIVES
    • 10.1.6 CURRENT FOCUS & STRATEGIES
    • 10.1.7 THREAT FROM COMPETITION
    • 10.1.8 SWOT ANALYSIS
  • 10.2 MEDTRONIC PLC
  • 10.3 F. HOFFMANN-LA ROCHE LTD.
  • 10.4 BAYER AG
  • 10.5 LIFESCAN, INC.
  • 10.6 DEXCOM, INC.
  • 10.7 SANOFI
  • 10.8 INSULET CORPORATION
  • 10.9 ASCENSIA DIABETES CARE HOLDINGS AG
  • 10.10 B BRAUN MELSUNGEN AG
  • 10.11 ABOUT VERIFIED MARKET INTELLIGENCE
  • 10.12 DYNAMIC DATA VISUALIZATION